EMA Panel Backs Approval of Revolution’s Pancreatic Cancer Drug

dagelijksestandaard.nl

welingelichtekringen.nl

View article

Reposted by

welingelichtekringen.nl

Right

Factuality

Ownership

AMSTERDAM (ANP) - A drug that could extend the lifespan of people with metastatic pancreatic cancer may enter the Dutch market, reports the Medicines Evaluation Board. After a trial with five hundred patients, the drug Rasonque received approval from the European...

Sueddeutsche Zeitung

Lean Left

Factuality

Ownership

Daraxonrasib, a new active substance against pancreatic cancer, is given green light by the European regulatory authority. It has used an accelerated test procedure similar to the Covid vaccines.

Handelsblatt

Lean Right

Factuality

Ownership

According to a study, a new drug prolongs the lives of people with advanced pancreatic cancer, but promises no cure. Now approval in Europe is a bit closer.

volksfreund.de

saarbruecker-zeitung.de

Center

View article

Reposted by

saarbruecker-zeitung.de

Center

Factuality

Ownership

According to a study, a new drug prolongs the lives of people with advanced pancreatic cancer, but promises no cure. Now approval in Europe is a bit closer.